09.07.2015 Views

Guidelines on the Management of Stable Angina Pectoris ... - Cardio

Guidelines on the Management of Stable Angina Pectoris ... - Cardio

Guidelines on the Management of Stable Angina Pectoris ... - Cardio

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

10 ESC <str<strong>on</strong>g>Guidelines</str<strong>on</strong>g>Table 4 Probability <strong>of</strong> cor<strong>on</strong>ary disease in symptomatic patients based <strong>on</strong> (a) age, gender, and symptom classificati<strong>on</strong> and (b) modified byexercise test results(a) Pretest likelihood <strong>of</strong> CAD in symptomatic patients according to age and sexAge (years) Typical angina Atypical angina N<strong>on</strong>-anginal chest painMale Female Male Female Male Female30–39 69.7 + 3.2 25.8 + 6.6 21.8 + 2.4 4.2 + 1.3 5.2 + 0.8 0.8 + 0.340–49 87.3 + 1.0 55.2 + 6.5 46.1 + 1.8 13.3 + 2.9 14.1 + 1.3 2.8 + 0.750–59 92.0 + 0.6 79.4 + 2.4 58.9 + 1.5 32.4 + 3.0 21.5 + 1.7 8.4 + 1.260–69 94.3 + 0.4 90.1 + 1.0 67.1 + 1.3 54.4 + 2.4 28.1 + 1.9 18.6 + 1.9(b) CAD post-test likelihood (%) based <strong>on</strong> age, sex, symptom classificati<strong>on</strong> and exercise-induced electrocardiographicST-segment depressi<strong>on</strong>Age (years) ST-depressi<strong>on</strong> (mV) Typical angina Atypical angina N<strong>on</strong>-anginal chest pain AsymptomaticMale Female Male Female Male Female Male Female30–39 0.00–0.04 25 7 6 1 1 ,1 ,1 ,10.05–0.09 68 24 21 4 5 1 2 40.00–0.14 83 42 38 9 10 2 4 ,10.00–0.19 91 59 55 15 19 3 7 10.00–0.24 96 79 76 33 39 8 18 3.0.25 99 93 92 63 68 24 43 1140–49 0.00–0.04 61 22 16 3 4 1 1 ,10.00–0.09 86 53 44 12 13 3 5 10.00–0.14 94 72 64 25 26 6 11 20.00–0.19 97 84 78 39 41 11 20 40.00–0.24 99 93 91 63 65 24 39 10.0.25 .99 98 97 86 87 53 69 2850–59 0.00–0.04 73 47 25 10 6 2 2 10.00–0.09 91 78 57 31 20 8 9 30.00–0.14 96 89 75 50 37 16 19 70.00–0.19 98 94 86 67 53 28 31 120.00–0.24 99 98 94 84 75 50 54 27.0.25 .99 99 98 95 91 78 81 5660–69 0.00–0.04 79 69 32 21 8 5 3 20.00–0.09 94 90 65 52 26 17 11 70.00–0.14 97 95 81 72 45 33 23 150.00–0.19 99 98 89 83 62 49 37 250.00–0.24 99 99 96 93 81 72 61 47.0.25 .99 99 99 98 94 90 85 76use <strong>of</strong> <strong>the</strong> Borg scale or similar method <strong>of</strong> quantifyingsymptoms may be used to allow comparis<strong>on</strong>s. 151 Reas<strong>on</strong>sto terminate an exercise test are listed in Table 5.In some patients, <strong>the</strong> exercise ECG may be n<strong>on</strong>c<strong>on</strong>clusive,for example, if at least 85% <strong>of</strong> maximum heartrate is not achieved in <strong>the</strong> absence <strong>of</strong> symptoms or ischaemia,if exercise is limited by orthopaedic or o<strong>the</strong>r n<strong>on</strong>cardiacproblems, or if ECG changes are equivocal. Unless<strong>the</strong> patient has a very low pre-test probability (,10% probability)<strong>of</strong> disease, an inc<strong>on</strong>clusive exercise test should befollowed by an alternative n<strong>on</strong>-invasive diagnostic test.Fur<strong>the</strong>rmore, a ’normal’ test in patients taking antiischaemicdrugs does not rule out significant cor<strong>on</strong>arydisease. 135 For diagnostic purposes, <strong>the</strong> test should be c<strong>on</strong>ductedin patients not taking anti-ischaemic drugs, althoughthis may not always be possible or c<strong>on</strong>sidered safe.Exercise stress testing can also be useful for prognosticstratificati<strong>on</strong>, 152 to evaluate <strong>the</strong> efficacy <strong>of</strong> treatmentafter c<strong>on</strong>trol <strong>of</strong> angina with medical treatment or revascularizati<strong>on</strong>or to assist prescripti<strong>on</strong> <strong>of</strong> exercise afterc<strong>on</strong>trol <strong>of</strong> symptoms, but <strong>the</strong> effect <strong>of</strong> routine periodicalexercise testing <strong>on</strong> patient outcomes has not been formallyevaluated.Recommendati<strong>on</strong>s for exercise ECG for initialdiagnostic assessment <strong>of</strong> anginaClass I(1) Patients with symptoms <strong>of</strong> angina and intermediatepre-test probability <strong>of</strong> cor<strong>on</strong>ary disease based <strong>on</strong> age,gender, and symptoms, unless unable to exercise or displaysECG changes which make ECG n<strong>on</strong>-evaluable(level <strong>of</strong> evidence B)Class IIb(1) Patients with 1 mm ST-depressi<strong>on</strong> <strong>on</strong> resting ECG ortaking digoxin (level <strong>of</strong> evidence B)(2) In patients with low pre-test probability (,10% probability)<strong>of</strong> cor<strong>on</strong>ary disease based <strong>on</strong> age, gender, andsymptoms (level <strong>of</strong> evidence B)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!